Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-29T19:13:30.389Z Has data issue: false hasContentIssue false
  • English
  • Français

Effects of short- and long-term feeding of L-carnitine and congeners on the production of eicosanoids from rat peritoneal leucocytes

Published online by Cambridge University Press:  06 August 2007

Ingrid M. Garrelds ,
Graham R. Elliott ,
Freek J. Zijlstra  and
Iván L. Bonta
Ingrid M. Garrelds
Affiliation:
Department of Pharmacology, Faculty of Medicine, Erasmus University Rotterdam, PO Box 1738, Rotterdam, The Netherlands
Graham R. Elliott
Affiliation:
Department of Pharmacology, Faculty of Medicine, Erasmus University Rotterdam, PO Box 1738, Rotterdam, The Netherlands
Freek J. Zijlstra
Affiliation:
Department of Pharmacology, Faculty of Medicine, Erasmus University Rotterdam, PO Box 1738, Rotterdam, The Netherlands
Iván L. Bonta
Affiliation:
Department of Pharmacology, Faculty of Medicine, Erasmus University Rotterdam, PO Box 1738, Rotterdam, The Netherlands
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The effect of short- and long-term feeding with L-carnitine, L-acetyl carnitine and L-propionyl carnitine on the production of eicosanoids front in vitro stimulated carrageenan-induced rat peritoneal macrophages was investigated. Both young (4 weeks) and old (18 months) rats were used. A lower number of cells was isolated from the peritonea of treated than control young rats after 4 d feeding, but after 60 d no differences were observed. A similar reduction in cell number was found when old animals were given L-acetyl carnitine or L-propionyl carnitine (acutely) or L-acetyl carnitine or L-carnitine (chronically). Plasma carnitine levels were higher in young rats given carnitine both chronically and acutely. Carnitine derivatives were without effect. In contrast, levels of total carnitine in the plasma of old rats given L-carnitine and L-acetyl carnitine for 4 d and 60 d were higher than in controls. There was no correlation between total plasma carnitine level and effects on prostaglandin, thromboxane and leukotriene B4 (LTB4) production. In young rats the most important changes were observed in relation to the production of prostacyclin (PGI2), measured as 6 keto-prostaglandin Flα. Prostacyclin production was higher in the groups given carnitine or its derivatives. The net result of the changes in PGI2 was that the 6 keto-prostaglandin F1α: thromboxane B2 and the 6 keto-prostaglandin Flα:LTB4 ratios tended to be higher in cells from young animals following short-term feeding with L-carnitine. When young rats were given carnitine compounds for 60 d PGI2 production was lower in cells from L-acetyl carnitine- and L-propionyl carnitine-fed animals. The net result of the changes in PGI2 was that the 6 keto-prostaglandin F1α: thromboxane B2 and the 6 keto-prostaglandin F1α:LTB4 ratios were lower in cells from animals fed with carnitine compounds. In old rats the PGI2 production was lower after short-term feeding with carnitine compounds and was higher after long-term feeding. LTB4 production was lower after L-carnitine and L-acetyl carnitine treatment for 4 d and also lower after 60 d treatment with L-acetyl carnitine. The net results of the changes in PGI2 were that the 6 keto-prostaglandin F1α: thromboxane B2 and the 6 keto-prostaglandin F1α:LTB4 ratios were lower after short-term feeding of all three compounds and higher after the long-term treatment with L-acetyl carnitine and L-propionyl carnitine in old rats. By long-term treatment with low-dose aspirin of patients with heart failure and claudication, the 6 keto-prostaglandin F1α: thromboxane B2 ratio is positively increased, which is a beneficial cardioprotective effect. The mechanism of action of carnitine in heart failure and claudication could also be achieved by an increase of this ratio. Our results suggest that elderly patients could be treated chronically by carnitine to obtain this beneficial effect.

Keywords

L-CarnitinePeritoneal macrophagesEicosanoids
Type
Carnitine and eicosanoid synthesis
Information
British Journal of Nutrition , Volume 72 , Issue 5 , November 1994 , pp. 785 - 793
Copyright
Copyright © The Nutrition Society 1994

References

REFERENCES

Adolfs, M. J. & Elliott, G. R. (1982) The stimulation by ethanol of rat aorta ring prostacyclin-like synthesis is related to the age of the animal. Agents and Actions 11, Suppl., 217–224.Google Scholar
Barth, P. G., Scholte, H. R., Berden, J. A, van der Klei-van Moorsel, J. M., Luyt-Houwen, I. E. M., van'tVeer-Korthof, E. Veer-Korthof, E., Th., van der, Harten, J. J. & Sobotka-Plojhar, M. A. (1983) An X-linked mitochondria1 disease affecting cardiac muscle, skeletal muscle and neutrophil leukocytes. Journal of the Neurological Sciences 62, 327–355.CrossRefGoogle Scholar
Campbell, W. B. (1990) Lipid-derived autocoids: eicosanoids and platelet activating factor. In The Pharmacological Basis of Therapeutics, 8th ed., pp. 600–617 [GilMann, A. G, Goodman, L. S., Rall, T. W., Nies, A. S. and Taylor, P., editors]. New York: Macmillan.Google Scholar
Christophersen, B. O. & Norseth, J. (1981) Arachidonic acid synthesis studied in isolated liver cells. Effects of (−)-carnitine and of (+)-decanoylcarnitine. FEBS Letters 133, 201–204.CrossRefGoogle Scholar
Conte, A., Fraticelli, G. & Ronca, G. (1992) Recent findings on the regulatory functions of CoA and the normalizing activity on plasma lipids of exogenous CoA. Drugs Under Experimental and Clinical Research 18, 179–188.Google Scholar
Elliott, G. R. & Adolfs, M. J. (1984) Continuous monitoring of prostacyclin production by the isolated, intact, rat aorta using a bioassay technique. Journal of Pharmacological Methods 11, 253–261.CrossRefGoogle ScholarPubMed
Elliott, G. R., Lauwen, A. P. M. & Bonta, I. L. (1990) The effect of acute feeding of carnitine, acetyl carnitine and propionyl carnitine on basal and A23187-stimulated eicosanoid release from rat carrageenan-elicited peritoneal macrophages. British Journal of Nutrition 64, 497–503.CrossRefGoogle ScholarPubMed
Haslam, R. J. & McClenaghan, M. D. (1981) Measurement of circulating prostacyclin. Nature 292, 364–366.CrossRefGoogle ScholarPubMed
Kallmann, R., Nieuwenhuis, H. K., de Groot, P. G., van Gijn, J. & Sixma, J. J. (1987) Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PGF1a excretion in healthy subjects. Thrombosis Research 45, 355–361.CrossRefGoogle Scholar
Lehmann, V., Benninghoff, B. & Droge, W. (1988) Tumor necrosis factor-induced activation of peritoneal macrophages is regulated by prostaglandin E2 and cAMP. Journal of Immunology 18, 957–959.Google Scholar
McGarry, J. D., Robles-Valdes, C. & Foster, D. W. (1975) Role of carnitine in hepatic ketogenesis. Proceedings of the National Academy of Sciences of the United States of America 72, 4385–4388.Google Scholar
Murakami, R., Momota, T., Yoshiya, K., Yoshikawa, N., Nakamura, H., Honda, M. & Ito, H. (1990) Serum carnitine and nutritional status in children treated with continuous ambulatory peritoneal dialysis. Journal of Pediatric Gastroenterology and Nutrition 11, 371–374.Google Scholar
Ohtsuka, Y. & Griffith, O. W. (1991) L-Carnitine protection in ammonia intoxication. Effect of aminocarnitine on carnitine-dependent metabolism and acute ammonia toxicity. Biochemical Pharmacology 41, 1957–1961.Google Scholar
Pande, S. V. & Caramancion, M. N. (1981) A simple radioisotopic assay of acetylcarnitine and acetyl-CoA at picomolar levels. Analytical Biochemistry 112, 30–38.Google Scholar
Rebouche, C. J. (1986) Carnitine metabolism and function in humans. Annual Review of Nutrition 6, 41–66.CrossRefGoogle ScholarPubMed
Rebouche, C. J. (1992) Carnitine function and requirements during the life cycle. FASEB Journal 6, 3379–3386.Google Scholar
Renz, H., Gond, J. H., Schmidt, A., Nain, M. & Gemsa, D. (1988) Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependent regulated by prostaglandin E2 and cyclic nucleotides. Journal of Immunology 141, 2388–2393.Google Scholar
Rossle, C., Kohse, K. P., Franz, H. E. & Furst, P. (1985) An improved method for the determination of free and esterified carnitine. Clinica Chimica Acta 149, 263–268.Google Scholar
Schepers, L., Casteels, M., Vamecq, J., Parmentier, G., van Veldhoven, P. P. & Mannaerts, G. P. (1988) β-Oxidation of the carboxyl side chain of prostaglandin E2 in rat liver peroxisomes and mitochondria. Journal of Biological Chemistry 263, 272–2731.Google Scholar
Schinetti, M. L. & Mazzini, A. (1986) Effect of L-carnitine on human neutrophil activity. International Journal of Tissue Reactions 8, 199–203.Google Scholar
Scholte, H. R., RodriguesPereira, R. Pereira, R., Busch, H. F., Jennekens, F. G., Luyt-Houwen, I. E. & Vaandrager-Verduin, M. H. Verduin, M. H. (1989) Carnitine deficiency, mitochondria1 dysfunction and the heart. Identical defect of oxidative phosphorylation in muscle mitochondria in cardiomyopathy due to carnitine loss and in Duchenne muscular dystrophy. Wiener Klinische Wochenschrift 6, 12–17.Google Scholar
Scholte, H. R., RodriguesPereira, R. Pereira, R., de Jonge, P. C., Luyt-Houwen, I. E., Hedwig, M., Verduin, M. & Ross, J. D. (1990) Primary carnitine deficiency. Journal of Clinical Chemistry and Clinical Biochemistry 28, 351–357.Google Scholar
Stryer, L. (1988) Biochemistry, 3rd ed., pp. 332, 472–475 and 484. New York: W. H.Freeman and Company.Google Scholar
Vincent, J. E. & Zijlstra, F. J. (1986). The effect of age on the prostaglandin formation in the rabbit aorta. Artery 13, 199–202.Google Scholar
Wanner, C., Riegel, W., Schaefer, R. M. & Horl, W. H. (1989) Carnitine and carnitine esters in acute rend failure. Nephrology Dialysis Transplantation 4, 951–956.CrossRefGoogle Scholar
Weksler, B. B., Pett, S. B., Alonso, D., Richter, R. C., Stelzer, P., Subramanian, V., Tack-Goldman, K. & Gay, W. A. (1983) Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. New England Journal of Medicine 308, 800–805.Google Scholar
Winter, S. C., Szabo-Aczel, S., Curry, C. J. R., Hutchinson, H. T., Hogue, R. & Shug, A. (1987) Plasma carnitine deficiency. Clinical observations in 51 pediatric patients. American Journal of Diseases of Children 141, 660–665.Google Scholar
Yamaoka, A., Sumimoto, H., Isobe, R. & Minakami, S. (1988) Formation of leukotriene B4-coenzyme A ester by rat liver microsomes. Biochemical and Biophysical Research Communications 154, 1248–1252.Google Scholar
Zijlstra, F. J. & Vincent, J. E. (1984) Determination of leukotrienes and prostaglandins in [14C]-arachidonic acid labelled human lung tissue by high-performance liquid chromatography and radioimmunoassay. Journal of Chromatography 311, 39–50.Google Scholar